NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...
Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall and winter immunization campaigns.
A growing number of U.S. adults are hesitant to get recommended vaccines this fall, a new survey found. Doctors discuss ...